Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 7;42(10):967-984.
doi: 10.1093/eurheartj/ehaa1044.

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists

Angela H E M Maas  1 , Giuseppe Rosano  2   3 , Renata Cifkova  4   5 , Alaide Chieffo  6 , Dorenda van Dijken  7 , Haitham Hamoda  8 , Vijay Kunadian  9 , Ellen Laan  10 , Irene Lambrinoudaki  11 , Kate Maclaran  12 , Nick Panay  13 , John C Stevenson  14 , Mick van Trotsenburg  15 , Peter Collins  14
Affiliations

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists

Angela H E M Maas et al. Eur Heart J. .

Erratum in

Abstract

Women undergo important changes in sex hormones throughout their lifetime that can impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors dominate in older age, there are several female-specific risk factors and inflammatory risk variables that influence a woman's risk at younger and middle age. Hypertensive pregnancy disorders and gestational diabetes are associated with a higher risk in younger women. Menopause transition has an additional adverse effect to ageing that may demand specific attention to ensure optimal cardiovascular risk profile and quality of life. In this position paper, we provide an update of gynaecological and obstetric conditions that interact with cardiovascular risk in women. Practice points for clinical use are given according to the latest standards from various related disciplines (Figure 1).

Keywords: Coronary artery disease; Female-specific risk factors; Hypertensive pregnancy disorders; Ischaemic heart disease; Menopausal hormone therapy; Menopause; Sexual health women; Transgender.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Female-specific risk factors and strategies for prevention. BP, blood pressure; CVD, cardiovascular disease; GDM, gestational diabetes mellitus; HPD, hypertensive pregnancy disorders; IHD, ischaemic heart disease; MHT, menopausal hormone therapy; OGTT, oral glucose tolerance test; PCOS, polycystic ovarian syndrome; POI, premature ovarian insufficiency.
See this image and copyright information in PMC

References

    1. Morabia A, Costanza MC. International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol 1998;148:1195–1205. - PubMed
    1. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 2008;60:210–241. - PMC - PubMed
    1. Menazza S, Murphy E. The expanding complexity of estrogen receptor signaling in the cardiovascular system. Circ Res 2016;118:994–1007. - PMC - PubMed
    1. Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocr Rev 2006;27:575–605. - PubMed
    1. Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol 2015;294:63–69. - PMC - PubMed